Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 4, 2024Cancer Research

Abstract A107: Characterizing the genomic and immunologic landscape of serous borderline tumors and low-grade serous ovarian cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

RKRahul KrishnanUniversity of TorontoABAgnes Julia BileczUniversity of ChicagoPHPaula HerbstUniversity of Chicago

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Krishnan et al. (2024) studied this question.

synapsesocial.com/papers/68e75dc8b6db6435876d49a2https://doi.org/10.1158/1538-7445.ovarian23-a107
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Changes in the tumour microenvironment mark the transition from serous borderline tumour to low‐grade serous carcinoma2024 · 3 citations
  2. 2Clinical, morphological, and molecular-genetic features of ovarian serous borderline tumors2025
  3. 3151 Ovarian High-Grade Serous Carcinoma associated with a Continuum of Borderline Tumor and Low-Grade Carcinoma Components in a Young Female with BRCA1 Germline Mutation: A Rare Association2025
  4. 4HER2 Status in Low-grade Serous Ovarian Tumors2024 · 6 citations
  5. 5Abstract 801: Genomic and spatial single-cell profiling reveals BRCA-linked tumor microenvironment signatures in high-grade serous ovarian carcinoma.2026